The Global Hemodialysis Catheters Market size is expected to reach $1.1 billion by 2030, rising at a market growth of 4.7% CAGR during the forecast period. In the year 2022, the market attained a volume of 29,033.2 thousand units experiencing a growth of 5.0% (2019-2022).
The aging demographic in North America has led to an increased incidence of kidney-related disorders. Consequently, the North American region would acquire nearly 25% of the total market share by 2030. The region's well-established healthcare infrastructure embraces technological improvements. North American healthcare facilities, including intensive care units (ICUs) and emergency departments, often prefer the use of these catheters for patients with acute kidney injury or other critical conditions requiring urgent renal replacement therapy.
The global increase in the prevalence of chronic kidney disease is a significant driver for the market. CKD is a common and progressive condition that often leads to end-stage renal disease (ESRD), necessitating renal replacement therapies like hemodialysis. Hypertension-related kidney disease is a common indication for hemodialysis, further fueling the demand for catheters. Obesity is recognized as a risk factor for CKD. The global rise in obesity rates, driven by changes in diet and lifestyle, contributes to the increasing incidence of CKD. Therefore, the market is expanding significantly due to the rising prevalence of chronic kidney disease. Additionally, Home-based dialysis allows patients to receive treatment without traveling to a healthcare facility. The comfort of undergoing dialysis at home is a compelling factor for many patients, and these catheters are integral to establishing vascular access for this mode of treatment. Home-based dialysis empowers patients to participate actively in their treatment, promoting independence. Patients using these catheters at home can take charge of their dialysis sessions, improving their quality of life and psychological well-being. Thus, increasing preference for home-based dialysis has been a pivotal factor in driving the growth of the market.
However, the market faces challenges related to regulatory compliance and standardization of practices. Ensuring that catheters meet stringent regulatory requirements while maintaining consistency in insertion techniques and care protocols is an ongoing challenge. Stringent regulatory requirements can act as barriers to entry for new companies looking to introduce novel catheters. The lengthy approval processes and high compliance standards may discourage smaller players from entering the market, reducing competition, and stifling innovation. Therefore, regulatory compliance and standardization are a significant challenge that hampers the growth of market.
Moreover, the pandemic disrupted global supply chains, affecting the production and distribution of medical devices, including these catheters. Manufacturers encountered obstacles such as facility closures, transportation disruptions, and raw material shortages, which caused production and distribution delays. Infection prevention become a paramount concern during the pandemic. Healthcare providers heightened their efforts to reduce the risk of catheter-related infections. This led to increased scrutiny of catheter insertion practices, a greater emphasis on sterile techniques, and exploring catheters with enhanced antimicrobial properties. Thus, the COVID-19 pandemic had a moderate effect on the market.
The aging demographic in North America has led to an increased incidence of kidney-related disorders. Consequently, the North American region would acquire nearly 25% of the total market share by 2030. The region's well-established healthcare infrastructure embraces technological improvements. North American healthcare facilities, including intensive care units (ICUs) and emergency departments, often prefer the use of these catheters for patients with acute kidney injury or other critical conditions requiring urgent renal replacement therapy.
The global increase in the prevalence of chronic kidney disease is a significant driver for the market. CKD is a common and progressive condition that often leads to end-stage renal disease (ESRD), necessitating renal replacement therapies like hemodialysis. Hypertension-related kidney disease is a common indication for hemodialysis, further fueling the demand for catheters. Obesity is recognized as a risk factor for CKD. The global rise in obesity rates, driven by changes in diet and lifestyle, contributes to the increasing incidence of CKD. Therefore, the market is expanding significantly due to the rising prevalence of chronic kidney disease. Additionally, Home-based dialysis allows patients to receive treatment without traveling to a healthcare facility. The comfort of undergoing dialysis at home is a compelling factor for many patients, and these catheters are integral to establishing vascular access for this mode of treatment. Home-based dialysis empowers patients to participate actively in their treatment, promoting independence. Patients using these catheters at home can take charge of their dialysis sessions, improving their quality of life and psychological well-being. Thus, increasing preference for home-based dialysis has been a pivotal factor in driving the growth of the market.
However, the market faces challenges related to regulatory compliance and standardization of practices. Ensuring that catheters meet stringent regulatory requirements while maintaining consistency in insertion techniques and care protocols is an ongoing challenge. Stringent regulatory requirements can act as barriers to entry for new companies looking to introduce novel catheters. The lengthy approval processes and high compliance standards may discourage smaller players from entering the market, reducing competition, and stifling innovation. Therefore, regulatory compliance and standardization are a significant challenge that hampers the growth of market.
Moreover, the pandemic disrupted global supply chains, affecting the production and distribution of medical devices, including these catheters. Manufacturers encountered obstacles such as facility closures, transportation disruptions, and raw material shortages, which caused production and distribution delays. Infection prevention become a paramount concern during the pandemic. Healthcare providers heightened their efforts to reduce the risk of catheter-related infections. This led to increased scrutiny of catheter insertion practices, a greater emphasis on sterile techniques, and exploring catheters with enhanced antimicrobial properties. Thus, the COVID-19 pandemic had a moderate effect on the market.
By Tip Configuration Analysis
Based on tip configuration, the market is classified into step-tip catheters, split-tip catheters, and symmetric catheters. The split-tip catheters segment acquired a substantial revenue share in the market in 2022. Split-tip catheters are designed to minimize trauma during insertion. The design of split-tip catheters is often compatible with ultrasound guidance during insertion. Ultrasound-guided catheter placement allows for real-time visualization of blood vessels, enhancing accuracy and safety during insertion. Catheter-related infections are a significant concern in hemodialysis. Split-tip catheters often incorporate features to minimize the risk of infections. The design reduces the potential for microbial adherence, contributing to improved catheter hygiene and patient safety.By End User Analysis
By end user, the market is segmented into hospitals, clinics/dialysis centres, and home dialysis. The clinics/dialysis centres segment recorded a remarkable revenue share in the market in 2022. Using clinics and dialysis centers offers a more convenient option for patients requiring regular hemodialysis treatments. Patients can schedule appointments for dialysis sessions at these centers, allowing for flexibility in managing their healthcare needs. The availability of clinics and dialysis centers helps alleviate the burden on hospitals by providing specialized renal care outside of the hospital setting. This decentralized approach enables hospitals to focus on critical care services while clinics and dialysis centers handle routine hemodialysis procedures using catheters.
By Material Analysis
By material, the market is categorized into silicone and polyurethane. The silicone segment covered a considerable revenue share in the market in 2022. When used in these catheters, silicone reduces the risk of adverse reactions and inflammation, making it suitable for prolonged vascular access. Silicone is a flexible and soft material, contributing to the ease of catheter insertion and patient comfort. The flexibility of silicone catheters allows for easier maneuverability during the insertion process, minimizing trauma to blood vessels.By Product Analysis
On the basis of product, the market is divided into non-cuffed tunneled, cuffed tunneled, non-tunneled. The non-cuffed tunneled segment garnered a significant revenue share in the market in 2022. Non-cuffed tunneled catheters are designed to optimize vascular access for hemodialysis. The tunneled nature of these catheters provides a secure pathway from the skin surface to the target blood vessel, ensuring stability and minimizing the risk of dislodgment. The design of non-cuffed tunneled catheters often includes features that minimize trauma during insertion and removal. This is important for preserving the integrity of blood vessels and reducing the risk of complications associated with catheter placement and removal procedures.By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region led the market by generating the highest revenue share. Growing awareness about kidney diseases and the importance of early diagnosis and treatment influences healthcare-seeking behavior in the Asia Pacific region. The increasing disposable income and healthcare spending in certain economies within the Asia Pacific region contribute to improved access to healthcare services, including renal replacement therapies.List of Key Companies Profiled
- Teleflex Incorporated
- Medtronic Plc
- AngioDynamics, Inc.
- Bayer Ag
- B.Braun Melsungen AG
- Baxter International, Inc
- NIPRO Corporation
- Covalon Technologies Ltd.
- Fresenius Medical Care AG & Co. KGaA
- DaVita Inc.
Market Report Segmentation
By Material (Volume, Thousand Units, USD Billion, 2019-2030)- Polyurethane
- Silicone
- Cuffed Tunneled
- Non-Cuffed Tunneled
- Non-Tunneled
- Step-Tip Catheters
- Split-Tip Catheters
- Symmetric Catheters
- Hospitals
- Clinics/Dialysis Centers
- Home Dialysis
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global Hemodialysis Catheters Market by Material
Chapter 5. Global Hemodialysis Catheters Market by Product
Chapter 6. Global Hemodialysis Catheters Market by Tip Configuration
Chapter 7. Global Hemodialysis Catheters Market by End User
Chapter 8. Global Hemodialysis Catheters Market by Region
Chapter 9. Company Profiles
Companies Mentioned
- Teleflex Incorporated
- Medtronic Plc
- AngioDynamics, Inc.
- Bayer Ag
- B. Braun Melsungen AG
- Baxter International, Inc
- NIPRO Corporation
- Covalon Technologies Ltd.
- Fresenius Medical Care AG & Co. KGaA
- DaVita Inc.
Methodology
LOADING...
